budralazine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antihypertensives, hydrazinephthalazine derivatives 421 36798-79-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • budralazine
  • buterazine
  • budralazine monohydrochloride
  • budralazine hydrochloride
  • budralazine HCl
  • Molecular weight: 240.31
  • Formula: C14H16N4
  • CLOGP: 2.70
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 1
  • TPSA: 49.11
  • ALOGS: -3.68
  • ROTB: 2

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000959 Antihypertensive Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D014665 Vasodilator Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.92 Basic
pKa2 3.95 Basic
pKa3 1.56 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01997 KEGG_DRUG
C0054203 UMLSCUI
CHEBI:134979 CHEBI
CHEMBL2107516 ChEMBL_ID
6419536 PUBCHEM_CID
C006153 MESH_SUPPLEMENTAL_RECORD_UI
3750 INN_ID
S0177QHV2B UNII

Pharmaceutical products:

None